HYPOLIPIDEMIC AND PLEIOTROPIC EFFECTS OF ATORVASTATIN TREATMENT IN PERIPHERAL ARTERY DISEASE PATIENTS WITH DYSLIPIDEMIA Article Buzin A., Baranov A., Obukhov A., Sharkova N., Bocharova M., Puzenko D., Obukhov D. European Heart Journal. Vol. 29. 2008. P. 144-144
HAEMODYNAMIC AND CLINICAL EFFECTS OF ULARITIDE IN DECOMPENSATED HEART FAILURE Article Mitrovic V., Seferovic P.M., Simeunovic D., Ristic A.D., Miric M., Moiseyev V.S., Kobalava Z., Nitsche K., Forssmann W.-G., Lüss H., Meyer M. European Heart Journal. Vol. 27. 2006. P. 2823-2832
SAFETY AND EFFICACY OF A NOVEL CALCIUM SENSITIZER, LEVOSIMENDAN, IN PATIENTS WITH LEFT VENTRICULAR FAILURE DUE TO AN ACUTE MYOCARDIAL INFARCTION: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY (RUSSLAN) Article Moiseyev V.S., Põder P., Andrejevs N., Ruda M.Y., Golikov A.P., Lazebnik L.B., Kobalava Z.D., Lehtonen L.A., Laine T., Nieminen M.S., Lie K.I. European Heart Journal. Vol. 23. 2002. P. 1422-1432